Altria Group, Inc. v. Good

Smokers of Marlboro Lights and Cambridge Lights cigarettes filed suit against their manufacturers for violating the Maine Unfair Trade Practices Act (MUTPA) by fraudulently misleading plaintiffs about the harmful health effects of "light" and "lowered tar and nicotine" cigarettes. The district court granted the defendants' motion for summary judgment, finding that the cause of action was essentially a smoking-and-health claim that was expressly preempted by the Federal Cigarette Labeling and Advertising Act (FCLAA). The appellate court reversed the district court, and the Supreme Court affirmed that reversal.  The Supreme Court held that the MUTPA's duty to not deceive is not a regulation of smoking and health and is therefore not preempted by the FCLAA. The Court further held that the Federal Trade Commission's prior decisions pertaining to tar and nicotine content in cigarettes do not provide a basis for implied preemption.

Altria Group, Inc., et al. v. Good, et al., 555 U.S. 70, Supreme Court of the United States (2008).

  • United States
  • Dec 15, 2008
  • Supreme Court of the United States

Parties

Plaintiff

  • Altria Group, Inc.
  • Others

Defendant

  • Others similarly situated
  • Stephanie Good

Legislation Cited

Federal Cigarette Labeling and Advertising Act (as amended), 15 USC §§ 1331 - 1341

Comprehensive Smoking Education Act, 15 U.S. Code Section 1333(a)

Federal Cigarette Labeling and Advertising Act, 15 U.S. Code Section 1334(b)

Related Documents

Type of Litigation

Tobacco Control Topics

Substantive Issues

Type of Tobacco Product

None

"We conclude, as we did in Cipollone, that the Labeling Act does not pre-empt state-law claims like respondents' that are predicated on the duty not to deceive. We also hold that the FTC's various decisions with respect to statements of tar and nicotine content do not impliedly pre-empt respondents' claim. Respondents still must prove that petitioners' use of "light" and "lowered tar" descriptors in fact violated the state deceptive practices statute, but neither the Labeling Act's pre-emption provision nor the FTC's actions in this field prevent a jury from considering that claim. Accordingly, the judgment of the Court of Appeals is affirmed, and the case is remanded for further proceedings consistent with this opinion."
"Based on these events, petitioners assert that "the FTC has required tobacco companies to disclose tar and nicotine yields in cigarette advertising using a government-mandated testing methodology and has authorized them to use descriptors as shorthand references to those numerical test results." Brief for Petitioners 2 (emphasis in original). As the foregoing history shows, however, the FTC has in fact never required that cigarette manufacturers disclose tar and nicotine yields, nor has it condoned representations of those yields through the use of "light" or "low tar" descriptors. Subsequent Commission actions further undermine petitioners' claim. After the tobacco companies agreed to report tar and nicotine yields as measured by the Cambridge Filter Method, the FTC continued to police cigarette companies' misleading use of test results. In 1983, the FTC responded to findings that tar and nicotine yields for Barclay cigarettes obtained through Cambridge Filter Method testing were deceptive because the cigarettes in fact delivered disproportionately more tar to smokers than other cigarettes with similar Cambridge Filter Method ratings. 48 Fed. Reg. 15954. And in 1995, the FTC found that a manufacturer's representation "that consumers will get less tar by smoking ten packs of Carlton brand cigarettes than by smoking a single pack of the other brands" was deceptive even though it was based on the results of Cambridge Filter Method testing. In re American Tobacco Co., 119 F. T. C. 3, 4. The FTC's conclusion was based on its recognition that, "[i]n truth and in fact, consumers will not necessarily get less tar" due to "such behavior as compensatory smoking." This history shows that, contrary to petitioners' suggestion, the FTC has no longstanding policy authorizing collateral representations based on Cambridge Filter Method test results. Rather, the FTC has endeavored to inform consumers of the comparative tar and nicotine content of different cigarette brands and has in some instances prevented misleading representations of Cambridge Filter Method test results. The FTC's failure to require petitioners to correct their allegedly misleading use of "light" descriptors is not evidence to the contrary; agency nonenforcement of a federal statute is not the same as a policy of approval."
"In sum, we conclude now, as the plurality did in Cipollone, that "the phrase `based on smoking and health' fairly but narrowly construed does not encompass the more general duty not to make fraudulent statements." 505 U. S., at 529."
"It is true, as petitioners argue, that the appeal of their advertising is based on the relationship between smoking and health. And although respondents have expressly repudiated any claim for damages for personal injuries, see App. 26a, their actual injuries likely encompass harms to health as well as the monetary injuries they allege. These arguments are unavailing, however, because the text of §1334(b) does not refer to harms related to smoking and health. Rather, it pre-empts only requirements and prohibitions—i.e., rules—that are based on smoking and health. The MUTPA says nothing about either "smoking" or "health." It is a general rule that creates a duty not to deceive and is therefore unlike the regulations at issue in Reilly."